Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB vs NEFAZODONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATALIZUMAB vs NEFAZODONE: Safety Overview

Metric NATALIZUMAB NEFAZODONE
Total FAERS Reports 64,315 284
Deaths Reported 3,140 11
Death Rate 4.9% 3.9%
Hospitalizations 17,879 37
Average Patient Age 45.6 yrs 56.4 yrs
% Female Patients 78.5% 66.6%
FDA Approval Date N/A Dec 22, 1994
Manufacturer Sandoz Inc Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued